glutathione and ovarian cancer in Cancer: A Double-Edged Sword Glutathione as a Prognostic Biomarker
Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer Frontiers Unveiling drug resistance pathways in high grade serous ovarian cancer(HGSOC): recent advances and future perspectives how does glutathione s transferase cause drug resistance in cancer cells Simplified scheme of action of the enzymes S transferases Chemotherapy Resistance of Ovarian Cancer PDF) Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




